
Loss-of-function variants in SF3B2 were identified in five new CFM families. Using zebrafish and human stem cell models, researchers showed that SF3B2 disruption leads to neural crest cell apoptosis, impaired proliferation, and defective craniofacial development. RNA sequencing revealed widespread splicing defects, implicating both Tp53-dependent and independent mechanisms. These findings deepen understanding of SF3B2-related craniofacial disorders and highlight targets for future research.
Like
Save
Share